The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Barinov S.V.

Omsk State Medical University

Kadtsyna T.V.

Omsk State Medical University

Tirskaya Yu.I.

Omsk State Medical University

Lazareva O.V.

Omsk State Medical University

Chulovskii Yu.I.

Omsk State Medical University

Zyryanova I.N.

Maternity Hospital No. 2

Zhivotchenko O.Yu.

Maternity Hospital No. 2

Kazakova M.B.

Omsk State Medical University

Orlitskaya A.D.

Omsk State Medical University

Experience in the use of immunochromatographic test of insulin-like growth factor binding protein-1 in the diagnosis of premature rupture of fetal membranes

Authors:

Barinov S.V., Kadtsyna T.V., Tirskaya Yu.I., Lazareva O.V., Chulovskii Yu.I., Zyryanova I.N., Zhivotchenko O.Yu., Kazakova M.B., Orlitskaya A.D.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2024;24(1): 6‑11

DOI: 10.17116/rosakush2024240116

Read: 1514 times

Download PDF (RU)
Contact the author
Table of contents

EXPERIENCE IN THE USE OF IMMUNOCHROMATOGRAPHIC TEST OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 IN THE DIAGNOSIS OF PREMATURE RUPTURE OF FETAL MEMBRANES
EXPERIENCE IN THE USE OF IMMUNOCHROMATOGRAPHIC TEST OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 IN THE DIAGNOSIS OF PREMATURE RUPTURE OF FETAL MEMBRANES

To cite this article:

Barinov SV, Kadtsyna TV, Tirskaya YuI, et al. . Experience in the use of immunochromatographic test of insulin-like growth factor binding protein-1 in the diagnosis of premature rupture of fetal membranes. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(1):6‑11. (In Russ.)
https://doi.org/10.17116/rosakush2024240116

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Disturbance of hydrogen sulfide meta­bolism in the placenta and amniotic fluid in fetal growth reta­rdation. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):5-10
Abstract:

OBJECTIVE

To evaluate the effectiveness of the test-system based on the determination of insulin-like growth factor binding protein-1 (ILGFBP-1) for the diagnosis of premature rupture of the fetal membranes.

MATERIAL AND METHODS

A retrospective, controlled study was carried out in which 200 patients with gestational age 37—41 weeks were included: 100 pregnant women with premature rupture of fetal membranes (main group), 100 women with timely amniotic fluid shedding in labor (comparison group). In both groups, test systems were used to detect amniotic fluid leakage: nitrazine test (pH determination), ILGFBP-1 determination, and Zeywang test (microscopic examination of vaginal contents). The sensitivity, specificity, prognostic value of positive and negative results were determined.

RESULTS

The best results were demonstrated by the test based on ILGFBP-1 determination (sensitivity 80%, specificity 100%) in comparison with the nitrazine test (sensitivity 71%, specificity 100%) and Zeywang test (sensitivity 55%, specificity 91.9%).

CONCLUSION

Test-systems for diagnostics of premature rupture of fetal membranes on the basis of ILGFBP-1 determination allows to carry out qualitative diagnostics and make a choice of optimal tactics of patient management.

Keywords:

premature rupture of fetal membranes
amniotic fluid
nitrazine test
determination of insulin-like growth factor binding protein-1
Zeiwang test

Authors:

Barinov S.V.

Omsk State Medical University

Kadtsyna T.V.

Omsk State Medical University

Tirskaya Yu.I.

Omsk State Medical University

Lazareva O.V.

Omsk State Medical University

Chulovskii Yu.I.

Omsk State Medical University

Zyryanova I.N.

Maternity Hospital No. 2

Zhivotchenko O.Yu.

Maternity Hospital No. 2

Kazakova M.B.

Omsk State Medical University

Orlitskaya A.D.

Omsk State Medical University

Received:

21.04.2023

Accepted:

16.05.2023

Close metadata

References:

  1. Kuz’min VN. Perinatal outcomes in premature rupture of membranes. Lechashchii vrach. 2018;3:34-38. (In Russ.).
  2. Menon R, Richardson LS. Preterm prelabor rupture of the membranes: A disease of the fetal membranes. Semin Perinatol. 2017;41:7:409-419.  https://doi.org/10.1053/j.semperi.2017.07.012
  3. Meller CH, Carducci ME, Ceriani Cernadas JM, Otaño L. Preterm premature rupture of membranes. Arch Argent Pediatr. 2018;116:4:575-581.  https://doi.org/10.5546/aap.2018.eng.e575
  4. Saryeva OP, Vakhromeev AP, Pareishvili VV. Pathomorphology of fetal membranes in their premature rupture. Akusherstvo i ginekologiya. Novosti. Mneniya. Obuchenie. 2020;8;1:27:105-106. (In Russ.).
  5. Oboskalova TA, Maksimyak OV. Premature rupture of membranes in full-term pregnancy. Rossiiskii vestnik akushera-ginekologa. 2021;21:1:54-60. (In Russ.). https://doi.org/10.17116/rosakush20212101154
  6. Sari IM, Adisasmita AC, Prasetyo S, Amelia D, Purnamasari R. Effect of premature rupture of membranes on preterm labor: a case-control study in Cilegon, Indonesia. Epidemiol Health. 2020;42:2020025. https://doi.org/10.4178/epih.e2020025
  7. Ghafoor S. Current and emerging strategies for prediction and diagnosis of prelabour rupture of the membranes: a narrative review. Malays J Med Sci. 2021;28:3:5-17.  https://doi.org/10.21315/mjms2021.28.3.2
  8. Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017;3:3:CD004735. https://doi.org/10.1002/14651858.cd004735.pub4
  9. Tosheva II, Ikhtiyarova GA. Pregnancy outcomes in preterm premature rupture of the membranes. RMZh. Mat’ i ditya. 2020;3:1:16-19. (In Russ.). https://doi.org/10.32364/2618-8430-2020-3-1-16-19
  10. Lorthe E, Torchin H, Delorme P, Ancel PY, Marchand-Martin L, Foix-L’Hélias L, Benhammou V, Gire C, d’Ercole C, Winer N, Sentilhes L, Subtil D, Goffinet F, Kayem G. Preterm premature rupture of membranes at 22-25 weeks’ gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Am J Obstet Gynecol. 2018;219:3:298-298.  https://doi.org/10.1016/j.ajog.2018.05.029
  11. Middleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017;1:1:CD005302. https://doi.org/10.1002/14651858.CD005302.pub3
  12. Baev OR, Tysyachnyj OV, Klimov VA, Balashov IS. Clinical and economic effectiveness of a placental a-microglobulin-1 test and that of the clinical diagnosis of premature rupture of membranes. Akusherstvo i ginekologiya. 2019;8:71-76. (In Russ.). https://doi.org/10.18565/aig.2019.8.71-76
  13. Baev OR, Dikke GB. Diagnosis of premature rupture of membranes based on biochemical tests. Akusherstvo i ginekologiya. 2018;9:132-136. (In Russ.). https://doi.org/10.18565/aig.2018.9.132-136
  14. Tazhetdinov EKh, Apresyan SV, Bondarenko KV, Gagaev ChG. Comparative effectiveness of additional methods for diagnosing premature rupture of membranes. Akusherstvo i ginekologiya. 2015;1:38-41. (In Russ.).
  15. Tazhetdinov EKh, Apresyan SV, Gagaev ChG. The effectiveness of a rapid test based on the determination of placental α-microglobulin in the diagnosis of premature rupture of the membranes. Farmateka. 2014;4:44-45. (In Russ.).
  16. Julien M, N’guema L, Bouzerara A, Toro B, Lecarpentier E, Guibourdenche J. Rupture prématurée des membranes: étude comparative des performances analytiques des tests de diagnostic biologique. [Premature rupture of the membranes: analytical evaluation of diagnostic tests]. Ann Biol Clin (Paris). 2018;76:3:300-306. (In French). https://doi.org/10.1684/abc.2018.1346
  17. Lecerf M, Vardon D, Morello R, Lamendour N, Dreyfus M. Comparaison des performances diagnostiques de deux tests de rupture prématurée des membranes (IGFBP-1/PAMG-1) en pratique clinique [Comparison of diagnostic performance of two tests of premature rupture of membranes (IGFBP-1/PAMG-1) in clinical practice]. J Gynecol Obstet Biol Reprod (Paris). 2015;44:9:832-839. (In French). https://doi.org/10.1016/j.jgyn.2014.10.012
  18. Eleje GU, Ezugwu EC, Ezebialu IU, Ojiegbe NO, Egeonu RO, Obiora CC, Okafor CG, Ikechebelu JI, Eke AC. Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes. Int J Gynaecol Obstet. 2019;144:2:180-186.  https://doi.org/10.1002/ijgo.12703
  19. Palacio M, Kühnert M, Berger R, Larios CL, Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: Comparison of performance indexes. BMC Pregnancy Childbirth. 2014;14:183. 
  20. Baev OR, Vasil’chenko ON, Rumyantseva VP, Shakhmaeva AB, Kozlova OA. The accuracy of diagnosing premature rupture of the membranes and the independent use of the test for determining PAMG-1 in a pregnant woman. Akusherstvo i ginekologiya. 2014;3:39-43. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.